+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The role of lipotoxicity in smoke cardiomyopathy



The role of lipotoxicity in smoke cardiomyopathy



Plos One 9(12): E113739



Experimental and clinical studies have shown the direct toxic effects of cigarette smoke (CS) on the myocardium, independent of vascular effects. However, the underlying mechanisms are not well known. Wistar rats were allocated to control (C) and cigarette smoke (CS) groups. CS rats were exposed to cigarette smoke for 2 months. After that morphometric, functional and biochemical parameters were measured. The echocardiographic study showed enlargement of the left atria, increase in the left ventricular systolic volume and reduced systolic function. Within the cardiac metabolism, exposure to CS decreased beta hydroxy acyl coenzyme A dehydrogenases and citrate synthases and increased lactate dehydrogenases. Peroxisome proliferator-activated receptor alpha (PPARα) and peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α) were expressed similarly in both groups. CS increased serum lipids and myocardial triacylglycerols (TGs). These data suggest that impairment in fatty acid oxidation and the accumulation of cardiac lipids characterize lipotoxicity. CS group exhibited increased oxidative stress and decreased antioxidant defense. Finally, the myocyte cross-sectional area and active Caspase 3 were increased in the CS group. The cardiac remodeling that was observed in the CS exposure model may be explained by abnormalities in energy metabolism, including lipotoxicity and oxidative stress.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059104812

Download citation: RISBibTeXText

PMID: 25462161

DOI: 10.1371/journal.pone.0113739


Related references

The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy. Expert Review of Cardiovascular Therapy 12(3): 345-358, 2014

Role of cardiac steatosis and lipotoxicity in obesity cardiomyopathy. Hypertension 57(2): 148-150, 2011

Fatty old hearts: role of cardiac lipotoxicity in age-related cardiomyopathy. Pathobiology of Aging and Age Related Diseases 6: 32221, 2016

A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy. Circulation 106(19 Supplement): II-206, November 5, 2002

A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proceedings of the National Academy of Sciences of the United States of America 100(3): 1226-1231, 2003

A critical role for PPARa-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content. Proceedings of the National Academy of Sciences of the United States of America 100(3): 26-31, 2003

The critical role of Astragalus polysaccharides for the improvement of PPARα [ correction of PPRAα]-mediated lipotoxicity in diabetic cardiomyopathy. Plos One 7(10): E45541-E45541, 2013

Fetuin A promotes lipotoxicity in β cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity. Molecular and Cellular Endocrinology 412: 1-11, 2016

A mouse model reveals an important role for catecholamine-induced lipotoxicity in the pathogenesis of stress-induced cardiomyopathy. European Journal of Heart Failure 15(1): 9-22, 2013

Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovascular Research 92(1): 10-18, 2012

Cardiac-specific ablation of ARNT leads to lipotoxicity and cardiomyopathy. Journal of Clinical Investigation 124(11): 4795-4806, 2015

Inhibition of ceramide biosynthesis decreases cardiomyopathy in lipoprotein lipase (LpL) lipotoxicity. 2007

New mechanism of lipotoxicity in diabetic cardiomyopathy: Deficiency of Endogenous H 2 S Production and ER stress. Mechanisms of Ageing and Development 162: 46-52, 2016

Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation. Circulation. Heart Failure 7(2): 327-339, 2014

Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function. American Journal of Physiology. Heart and Circulatory Physiology 297(6): H2096-H2108, 2010